Ophthalmic Surg Lasers Imaging Retina. 2023 Nov;54(11):650-653. doi: 10.3928/23258160-20230922-01. Epub 2023 Nov 1.
Many interventions for nonarteritic central retinal artery occlusion (CRAO) are associated with serious complications and little effect on visual outcomes. We report on the findings of a Cochrane systematic review that searched seven databases for peer-reviewed articles reporting on treatments for acute nonarteritic CRAO. We assessed six randomized controlled trials, including interventions such as tissue plasminogen activator (t-PA), isovolumic hemodilution, eyeball massage, intraocular pressure reduction, anticoagulation, vasodilation, oxygen inhalation, laser embolysis, transcorneal electrical stimulation, thrombolysis, pentoxifylline, and enhanced external counterpulsation. However, none of the randomized controlled trials demonstrated significant improvement in visual acuity at 1 month compared to observation, and some patients treated with t-PA experienced serious adverse effects including intracranial hemorrhage. Proposed interventions for acute nonarteritic CRAO may not be better than observation, but the evidence is uncertain. Larger, well-designed studies are necessary to determine the most effective management option for acute nonarteritic CRAO. .
许多针对非动脉炎性中央视网膜动脉阻塞(CRAO)的干预措施都伴随着严重的并发症,对视力结果的影响甚微。我们报告了一项 Cochrane 系统评价的结果,该评价在七个数据库中搜索了同行评审的文章,以报告治疗急性非动脉炎性 CRAO 的方法。我们评估了六项随机对照试验,包括组织型纤溶酶原激活物(t-PA)、等容血液稀释、眼球按摩、眼内压降低、抗凝、血管扩张、吸氧、激光解凝、经角膜电刺激、溶栓、己酮可可碱和增强型体外反搏等干预措施。然而,与观察相比,没有一项随机对照试验显示在 1 个月时视力有显著改善,一些接受 t-PA 治疗的患者出现了严重的不良反应,包括颅内出血。对于急性非动脉炎性 CRAO,提出的干预措施可能并不优于观察,但证据并不确定。需要更大、设计更好的研究来确定急性非动脉炎性 CRAO 最有效的治疗选择。